OPS
KRYS icon

Orion Portfolio Solutions’s Krystal Biotech KRYS Stock Holding History

Orion Portfolio Solutions’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$209K Buy
+1,160
New +$195K ﹤0.01% 1787
2024
Q4 		– Sell
-1,247
Closed -$227K – 1874
2024
Q3 		$227K Sell
1,247
-77
-6% -$14.8K ﹤0.01% 1657
2024
Q2 		$243K Sell
1,324
-148
-10% -$24.8K ﹤0.01% 1552
2024
Q1 		$262K Buy
+1,472
New +$204K ﹤0.01% 1510

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Orion Portfolio Solutions's KRYS Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in Krystal Biotech (KRYS) in Q1 2025: 1,160 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1787 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in KRYS as recently as Q3 2024.

Orion Portfolio Solutions first reported a position in KRYS in Q1 2024 and has held it in 4 quarters since. The position peaked at $262K in Q1 2024. 299 funds tracked by Wall St. Rank hold KRYS as of Q1 2025.

  • Orion Portfolio Solutions held 1,160 shares of Krystal Biotech worth $209K as of Q1 2025.
  • Krystal Biotech was a new Orion Portfolio Solutions position in Q1 2025.
  • Krystal Biotech made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1787 holding.
  • Orion Portfolio Solutions first reported a position in Krystal Biotech in Q1 2024 and has held it in 4 quarters since.
  • Orion Portfolio Solutions's Krystal Biotech position peaked at $262K in Q1 2024.
  • 299 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.